Galectin Therapeutics Inc. (GALT)

[biotech2010]

A. I was answering the prior post about trying to drum up interest in anything they have, it's a terrible way to run a company.

B. They announced an end to the psoriasis trials in August and now with one more patient who was in the that trial they are all excited about partnerships, it's a bad way to run a company and shows desperation. Why announce anything in August when you are still waiting for results?

C. The FX trial failed yet they continue to work on worthless crap (like those posters) that don't contribute to shareholder value. They are a drug company, not a non-invasive measurement instrument company. It's like Traber is looking for his next job after his over inflated salary goes away.

D. If you don't get it you don't get it, it doesn't matter to me, most of the other long term shareholders get it all too well